Nicholas Ingrassia
Director/Board Member bei LONGBOAT ENERGY PLC
Vermögen: 48 623 $ am 31.03.2024
Profil
Nicholas Andrew Ingrassia is currently an Executive Director & Director-Business Development at Longboat Energy Plc since 2020.
He is also currently the Head-Group Business Development at DNO North Sea Plc since 2017.
Previously, he worked as a Development Director at Salamander Energy Ltd.
from 2013 to 2014.
He also served as an Independent Non-Executive Director at AfriAg Global Plc.
In addition, he was a Non-Executive Director at Apollon Formularies Plc from 2021 to 2023.
Prior to that, he worked as a Manager-Investor Relations at Ithaca Petroleum Ltd.
from 2011 to 2012.
He also held the position of Country Manager at DNO ASA from 2019 to 2020.
Mr. Ingrassia graduated from the University of St. Andrews.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LONGBOAT ENERGY PLC
0,31% | 01.03.2023 | 179 023 ( 0,31% ) | 48 623 $ | 31.03.2024 |
Aktive Positionen von Nicholas Ingrassia
| Unternehmen | Position | Beginn |
|---|---|---|
| FAROE PETROLEUM PLC | Corporate Officer/Principal | 01.01.2017 |
| LONGBOAT ENERGY PLC | Director/Board Member | - |
Ehemalige bekannte Positionen von Nicholas Ingrassia
| Unternehmen | Position | Ende |
|---|---|---|
Apollon Formularies Plc
 Apollon Formularies Plc Pharmaceuticals: OtherHealth Technology Apollon Formularies Plc enganes in the development, market, distribution, and sale of legal hemp and medical cannabis products. It produces pharmaceutical, nutraceutical and other medical cannabis related products, including 3D printed sublingual, suppositories and capsules. Its products include Apollon NAUSEA, Apollon PAIN, Apollon SLEEP, Apollon ANTI-INFLAMMATORY, Apollon SEIZURES, Apollon APPETITE, and Apollon CANCER. The company is headquartered in Negril, Jamaica. | Director/Board Member | 03.08.2023 |
| DNO ASA | Corporate Officer/Principal | 01.07.2020 |
| SALAMANDER ENERGY PLC | Corporate Officer/Principal | - |
| AFRIAG GLOBAL PLC | Director/Board Member | - |
| ITHACA PETROLEUM LTD | Investor Relations Contact | - |
Ausbildung von Nicholas Ingrassia
| University of St. Andrews | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| DNO ASA | Energy Minerals |
| LONGBOAT ENERGY PLC | Industrial Services |
 | Health Technology |
| Private Unternehmen | 4 |
|---|---|
DNO North Sea Plc
 DNO North Sea Plc Oil & Gas ProductionEnergy Minerals DNO North Sea Plc engages in the exploration, appraisal, development, and production of oil and gas. The company was founded on December 19, 2002 and is headquartered in Aberdeen, the United Kingdom. | Energy Minerals |
Salamander Energy Ltd.
 Salamander Energy Ltd. Oil & Gas ProductionEnergy Minerals Salamander Energy Plc engages in the exploration, development, and production of upstream oil and gas. It focuses on building a portfolio of assets in Asia. The company was founded by James Menzies, Robert Maitland Cathery, Nicholas John Cooper, and Andrew Liam Cochran in September 13, 2006 and is headquartered in London, the United Kingdom. | Energy Minerals |
Ithaca Petroleum Ltd.
 Ithaca Petroleum Ltd. Contract DrillingIndustrial Services Ithaca Petroleum Ltd. engages in the exploration and development of oil and gas reserves. The company was founded by Peter Gordon Buchanan on September 7, 2004 and is headquartered in Leeds, the United Kingdom. | Industrial Services |
AfriAg Global Plc
 AfriAg Global Plc Medical SpecialtiesHealth Technology AfriAg Global Plc engages in investing by seeking to acquire a direct and indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. It focuses on opportunities in Africa, Europe, and the Middle East. The company was founded on June 17, 2008 and is headquartered in London, the United Kingdom. | Health Technology |
